Spiro Thiochromene-oxindoles As Novel Anti-inflammatory Agents: Design, Sustainable Synthesis, and Evaluations

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2025 Jan 6

PMID 39758897

Authors

Manju

Ashok Kumar Raigar

Kamlesh Saini

Nirmal Jyoti

Ravi Kumar Kapavarapu

Anjali Guleria

Affiliations

Soon will be listed here.

Abstract

A one-pot, acid-, base-, and metal-free, multicomponent strategy has been developed to synthesize spiro thiochromene-oxindole derivatives as potential anti-inflammatory agents. The synthesized compounds were screened for their anti-inflammatory activity by inhibiting heat-induced Bovine Serum Albumin (BSA) denaturation assay, revealing moderate to good efficacy. Compounds 4e, 4k, and 4h exhibited the highest activity, inhibiting BSA denaturation by 90.97-95.45% at 800 μg mL concentration with half maximal inhibitory concentration (IC) values of 127.477 ± 2.285, 190.738 ± 3.561, and 285.806 ± 8.894 μg mL, respectively. For mechanistic insights studies were conducted, revealing binding affinities of the active compounds with cyclooxygenase-2 (COX-2) protein, with binding energies of -8.9 kcal mol (4e), -8.7 kcal mol (4k), and -8.6 kcal mol (4h). Bioactivity and pharmacokinetic parameters were further analyzed, encompassing ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) characteristics. This study highlights the potential of spiro thiochromene-oxindoles as anti-inflammatory agents, warranting further exploration as potential leads. The synthetic strategy for these target compounds utilizes taurine as an eco-friendly bio-organic catalyst, facilitating an acid-, base-, and metal-free intramolecular C-S and C-C bond formation in aqueous media. The reaction involves a one-pot, three-component Knoevenagel-Thia-Michael cascade between substituted isatins, 1,3-dicarbonyls, and 2-naphthalene thiol. Key features of this green protocol include high yields, cost-efficiency, non-toxicity, atom economy, and acid-, base-, and metal-free synthesis in water. Additionally, the catalyst exhibits excellent reusability, maintaining its activity across three cycles with easy recovery, while product isolation is achieved through simple filtration, eliminating the need for chromatographic purification and organic solvents. These attributes underscore this approach's synthetic and environmental advantages, highlighting its potential for broader application in the development of anti-inflammatory agents.

References

Mishra C, Kumari S, Prakash A, Yadav R, Tiwari A, Pandey P . Discovery of novel Methylsulfonyl phenyl derivatives as potent human Cyclooxygenase-2 inhibitors with effective anticonvulsant action: Design, synthesis, in-silico, in-vitro and in-vivo evaluation. Eur J Med Chem. 2018; 151:520-532. DOI: 10.1016/j.ejmech.2018.04.007. View

Bandini M, Cozzi P, Giacomini M, Melchiorre P, Selva S, Umani-Ronchi A . Sequential one-pot InBr(3)-catalyzed 1,4- then 1,2-nucleophilic addition to enones. J Org Chem. 2002; 67(11):3700-4. DOI: 10.1021/jo0163243. View

Zebardast T, Zarghi A, Daraie B, Hedayati M, Dadrass O . Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorg Med Chem Lett. 2009; 19(12):3162-5. DOI: 10.1016/j.bmcl.2009.04.125. View

Netea M, Balkwill F, Chonchol M, Cominelli F, Donath M, Giamarellos-Bourboulis E . A guiding map for inflammation. Nat Immunol. 2017; 18(8):826-831. PMC: 5939996. DOI: 10.1038/ni.3790. View

Nekoofar M, Sadeghipanah M, Dehpour A . Evaluation of meloxicam (A cox-2 inhibitor) for management of postoperative endodontic pain: a double-blind placebo-controlled study. J Endod. 2003; 29(10):634-7. DOI: 10.1097/00004770-200310000-00005. View

Nathan C, Ding A . Nonresolving inflammation. Cell. 2010; 140(6):871-82. DOI: 10.1016/j.cell.2010.02.029. View

Huber M, Terezhalmy G . The use of COX-2 inhibitors for acute dental pain: A second look. J Am Dent Assoc. 2006; 137(4):480-7. DOI: 10.14219/jada.archive.2006.0220. View

Kim S, Lee S, Lee H, Shin M, Lee J . Design, Synthesis, and Biological Evaluation of 3-Substituted-Indolin-2-One Derivatives as Potent Anti-Inflammatory Agents. Int J Mol Sci. 2023; 24(3). PMC: 9916847. DOI: 10.3390/ijms24032066. View

Gupta A, Bah M . NSAIDs in the Treatment of Postoperative Pain. Curr Pain Headache Rep. 2016; 20(11):62. DOI: 10.1007/s11916-016-0591-7. View

10.

Nielsen O, Ainsworth M . Tumor necrosis factor inhibitors for inflammatory bowel disease. N Engl J Med. 2013; 369(8):754-62. DOI: 10.1056/NEJMct1209614. View

11.

Fu Y, Lu Z, Ma X, Fang K, He X, Xu H . One-pot cascade synthesis of benzopyrans and dihydropyrano[c]chromenes catalyzed by lipase TLIM. Bioorg Chem. 2020; 99:103888. DOI: 10.1016/j.bioorg.2020.103888. View

12.

Al-Hourani B, Sharma S, Mane J, Tuszynski J, Baracos V, Kniess T . Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett. 2011; 21(6):1823-6. DOI: 10.1016/j.bmcl.2011.01.057. View

13.

Pan T, He M, Deng L, Li J, Fan Y, Hao X . Design, Synthesis, and Evaluation of the COX-2 Inhibitory Activities of New 1,3-Dihydro--indolin-2-one Derivatives. Molecules. 2023; 28(12). PMC: 10305287. DOI: 10.3390/molecules28124668. View

14.

Gao Y, Duan Y . Increased COX2 in the trigeminal nucleus caudalis is involved in orofacial pain induced by experimental tooth movement. Anat Rec (Hoboken). 2010; 293(3):485-91. DOI: 10.1002/ar.21078. View

15.

Dallakyan S, Olson A . Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015; 1263:243-50. DOI: 10.1007/978-1-4939-2269-7_19. View

16.

Dionne R, Berthold C . Therapeutic uses of non-steroidal anti-inflammatory drugs in dentistry. Crit Rev Oral Biol Med. 2001; 12(4):315-30. DOI: 10.1177/10454411010120040301. View

17.

Laine L, White W, Rostom A, Hochberg M . COX-2 selective inhibitors in the treatment of osteoarthritis. Semin Arthritis Rheum. 2008; 38(3):165-87. DOI: 10.1016/j.semarthrit.2007.10.004. View

18.

Mohamadpour F . 3DPAFIPN as a halogenated dicyanobenzene-based photosensitizer catalyzed gram-scale photosynthesis of pyrano[2,3-d]pyrimidine scaffolds. Sci Rep. 2023; 13(1):13142. PMC: 10423215. DOI: 10.1038/s41598-023-40360-w. View

19.

Verma K, Tailor Y, Khandelwal S, Rushell E, Agarwal M, Kumar M . Efficient and environmentally sustainable domino protocol for the synthesis of diversified spiroheterocycles with privileged heterocyclic substructures using bio-organic catalyst in aqueous medium. Mol Divers. 2019; 24(4):1355-1365. DOI: 10.1007/s11030-019-09999-4. View

20.

Zarghi A, Najafnia L, Daraee B, Dadrass O, Hedayati M . Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorg Med Chem Lett. 2007; 17(20):5634-7. DOI: 10.1016/j.bmcl.2007.07.084. View